Argent Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-249,425
Closed -$2.25M 214
2017
Q1
$2.25M Buy
249,425
+5,800
+2% +$60.5K 0.09% 108
2016
Q4
$2.63M Buy
243,625
+17,675
+8% +$236K 0.11% 97
2016
Q3
$3.69M Buy
+225,950
New +$3.18M 0.16% 75
2014
Q2
Sell
-304,128
Closed -$2.41M 160
2014
Q1
$2.41M Sell
304,128
-39,825
-12% -$297K 0.13% 97
2013
Q4
$2.43M Sell
343,953
-98,850
-22% -$659K 0.14% 91
2013
Q3
$3.27M Buy
+442,803
New +$3.45M 0.2% 75

Other funds holding NPTN

Argent Capital Management's NPTN Position: Q2 2017 in Review

Argent Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q2 2017, closing a stake of 249,425 shares — an estimated $2.25M sold.

Argent Capital Management first reported a position in NPTN in Q3 2013 and held it in 6 quarters. The position peaked at $3.69M in Q3 2016. 101 funds tracked by Wall St. Rank hold NPTN as of Q2 2017.

  • Argent Capital Management reported no remaining NEOPHOTONICS CORP position as of Q2 2017 after selling out during the quarter.
  • Argent Capital Management sold 249,425 NEOPHOTONICS CORP shares in Q2 2017, an estimated $2.25M.
  • Argent Capital Management first reported a position in NEOPHOTONICS CORP in Q3 2013 and held it in 6 quarters.
  • Argent Capital Management's NEOPHOTONICS CORP position peaked at $3.69M in Q3 2016.
  • 101 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2017.

Based on Argent Capital Management's 13F filing for Q2 2017, filed 15 Aug 2017.